Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veridien Corporation was a life sciences company specializing in the development and commercialization of antimicrobial and infection control products. The company's flagship product line, marketed under the brand name Viraguard, included hospital-grade disinfectants, antiseptic hand sanitizers, and wipes designed to eliminate a broad spectrum of pathogens, including bacteria and viruses. Veridien's offerings were primarily targeted at healthcare facilities, emergency services, and the consumer health sector to prevent the spread of infectious diseases. Although the company was once publicly traded and achieved commercial status for its core technologies, it has since become inactive in the biotechnology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veridien.